{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-044828","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.388137+00:00","generated_at":"2026-05-30T02:19:24.069450+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Mangoceuticals enters CFO consulting agreement; $4k/month, 25k shares","bullets":["Consulting agreement with CFO Eugene Johnston effective Oct 1, 2024 for 12 months.","Cash compensation: $4,000 per month.","Equity: 25,000 shares of common stock under 2022 Equity Incentive Plan, vested on execution.","Agreement includes non-solicitation covenants and standard confidentiality.","Johnston continues as CFO; no change in leadership role."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-044828","json":"https://secwatch.observer/filing/0001493152-24-044828.json","markdown":"https://secwatch.observer/filing/0001493152-24-044828.md","text":"https://secwatch.observer/filing/0001493152-24-044828.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224044828/0001493152-24-044828-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224044828/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:19:24.069450+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}